These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 34218390)
21. Crystal structure of extended-spectrum beta-lactamase Toho-1: insights into the molecular mechanism for catalytic reaction and substrate specificity expansion. Ibuka AS; Ishii Y; Galleni M; Ishiguro M; Yamaguchi K; Frère JM; Matsuzawa H; Sakai H Biochemistry; 2003 Sep; 42(36):10634-43. PubMed ID: 12962487 [TBL] [Abstract][Full Text] [Related]
22. A gratuitous β-Lactamase inducer uncovers hidden active site dynamics of the Staphylococcus aureus BlaR1 sensor domain. Frederick TE; Peng JW PLoS One; 2018; 13(5):e0197241. PubMed ID: 29771929 [TBL] [Abstract][Full Text] [Related]
23. Investigations on recyclisation and hydrolysis in avibactam mediated serine β-lactamase inhibition. Choi H; Paton RS; Park H; Schofield CJ Org Biomol Chem; 2016 Apr; 14(17):4116-28. PubMed ID: 27072755 [TBL] [Abstract][Full Text] [Related]
24. Crystal structure of the E166A mutant of extended-spectrum beta-lactamase Toho-1 at 1.8 A resolution. Ibuka A; Taguchi A; Ishiguro M; Fushinobu S; Ishii Y; Kamitori S; Okuyama K; Yamaguchi K; Konno M; Matsuzawa H J Mol Biol; 1999 Feb; 285(5):2079-87. PubMed ID: 9925786 [TBL] [Abstract][Full Text] [Related]
25. Discrete backbone disorder in the nuclear magnetic resonance structure of apo intestinal fatty acid-binding protein: implications for the mechanism of ligand entry. Hodsdon ME; Cistola DP Biochemistry; 1997 Feb; 36(6):1450-60. PubMed ID: 9063893 [TBL] [Abstract][Full Text] [Related]
27. Crystal structure of the IMP-1 metallo beta-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad-spectrum inhibitor. Concha NO; Janson CA; Rowling P; Pearson S; Cheever CA; Clarke BP; Lewis C; Galleni M; Frère JM; Payne DJ; Bateson JH; Abdel-Meguid SS Biochemistry; 2000 Apr; 39(15):4288-98. PubMed ID: 10757977 [TBL] [Abstract][Full Text] [Related]
28. Complete ¹H, ¹⁵N, and ¹³C resonance assignments of Bacillus cereus metallo-β-lactamase and its complex with the inhibitor R-thiomandelic acid. Karsisiotis AI; Damblon C; Roberts GC Biomol NMR Assign; 2014 Oct; 8(2):313-8. PubMed ID: 23838816 [TBL] [Abstract][Full Text] [Related]
29. Atomic-resolution chemical characterization of (2x)72-kDa tryptophan synthase via four- and five-dimensional Klein A; Rovó P; Sakhrani VV; Wang Y; Holmes JB; Liu V; Skowronek P; Kukuk L; Vasa SK; Güntert P; Mueller LJ; Linser R Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35058365 [TBL] [Abstract][Full Text] [Related]
30. Probing the role of the conserved residue Glu166 in a class A β-lactamase using neutron and X-ray protein crystallography. Langan PS; Sullivan B; Weiss KL; Coates L Acta Crystallogr D Struct Biol; 2020 Feb; 76(Pt 2):118-123. PubMed ID: 32038042 [TBL] [Abstract][Full Text] [Related]
31. Avibactam and class C β-lactamases: mechanism of inhibition, conservation of the binding pocket, and implications for resistance. Lahiri SD; Johnstone MR; Ross PL; McLaughlin RE; Olivier NB; Alm RA Antimicrob Agents Chemother; 2014 Oct; 58(10):5704-13. PubMed ID: 25022578 [TBL] [Abstract][Full Text] [Related]
32. Investigation of ligand binding and protein dynamics in Bacillus subtilis chorismate mutase by transverse relaxation optimized spectroscopy-nuclear magnetic resonance. Eletsky A; Kienhöfer A; Hilvert D; Pervushin K Biochemistry; 2005 May; 44(18):6788-99. PubMed ID: 15865424 [TBL] [Abstract][Full Text] [Related]
33. Structural analysis of avibactam-mediated activation of the bla and mec divergons in methicillin-resistant Alexander JAN; Radaeva M; King DT; Chambers HF; Cherkasov A; Chatterjee SS; Strynadka NCJ J Biol Chem; 2020 Aug; 295(32):10870-10884. PubMed ID: 32518158 [TBL] [Abstract][Full Text] [Related]
34. Characterization of NADP+ binding to perdeuterated MurB: backbone atom NMR assignments and chemical-shift changes. Constantine KL; Mueller L; Goldfarb V; Wittekind M; Metzler WJ; Yanchunas J; Robertson JG; Malley MF; Friedrichs MS; Farmer BT J Mol Biol; 1997 Apr; 267(5):1223-46. PubMed ID: 9150408 [TBL] [Abstract][Full Text] [Related]
35. Variants of β-lactamase KPC-2 that are resistant to inhibition by avibactam. Papp-Wallace KM; Winkler ML; Taracila MA; Bonomo RA Antimicrob Agents Chemother; 2015 Jul; 59(7):3710-7. PubMed ID: 25666153 [TBL] [Abstract][Full Text] [Related]
37. Assessing the Potency of β-Lactamase Inhibitors with Diverse Inactivation Mechanisms against the PenA1 Carbapenemase from Nukaga M; Yoon MJ; Taracilia MA; Hoshino T; Becka SA; Zeiser ET; Johnson JR; Papp-Wallace KM ACS Infect Dis; 2021 Apr; 7(4):826-837. PubMed ID: 33723985 [No Abstract] [Full Text] [Related]
38. Atomic-Resolution Structure of a Class C β-Lactamase and Its Complex with Avibactam. Pozzi C; Di Pisa F; De Luca F; Benvenuti M; Docquier JD; Mangani S ChemMedChem; 2018 Jul; 13(14):1437-1446. PubMed ID: 29786960 [TBL] [Abstract][Full Text] [Related]
39. Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor. Ehmann DE; Jahić H; Ross PL; Gu RF; Hu J; Kern G; Walkup GK; Fisher SL Proc Natl Acad Sci U S A; 2012 Jul; 109(29):11663-8. PubMed ID: 22753474 [TBL] [Abstract][Full Text] [Related]